Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 130

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 130
---
0.94 |   |     |   |       |   |
| Pro forma net tangible book value per                                                      
 share of Common Stock after this offering                                                  |     |   |       |   |     | $ |  1.07 |   |
| Decrease in net tangible book value per                                                    
 share of Common Stock to investors in this offering                                        |     |   |       |   |     | $ | (0.93 | ) |

A $1.00 increase or decrease in the assumed public offering price of $2.00 per share of Common Stock, based on the last reported sale price for our Common Stock as reported on the Nasdaq Global Market on February 3, 2025, would decrease the number of shares of our Common Stock offered in this offering by approximately 1.3 million shares or increase the number of shares of our Common Stock offered in this offering by approximately 4.0 million shares. We may also increase or decrease the number of shares of Common Stock we are offering. An increase of 500,000 in the number of shares of Common Stock offered by us would increase our pro forma net tangible book value by approximately $0.9 million, or $0.05 per share, and decrease the amount of the decrease in net tangible value per share to investors participating in this offering by $0.05 per share, assuming the assumed offering price per share remains the same and after deducting the estimated placement agent commissions and estimated offering expenses payable by us. Similarly, a decrease of 500,000 in the number of shares of Common Stock offered by us would decrease our pro forma net tangible book value by approximately $0.9 million, a decrease of $0.06 per share, and increase the dilution of net tangible assets per share to investors participating in this offering by $0.06 per share, assuming the assumed offering price per share remains the same and after deducting the estimated placement agent commissions and estimated offering expenses payable by us. If we only sell 75%, 50% or 25% of the maximum offering amount, assuming the assumed offering price remains the same, our pro forma net tangible book value per share after this offering would be $0.94, $0.76 or $0.47, respectively, and the immediate dilution in net tangible book value per share to new investors purchasing securities in this offering would be $(1.06), $(1.24) or $(1.53), respectively, assuming no Purchase Warrants or Pre